High Throughput Screening Market
High Throughput Screening Market Forecasts to 2030 - Global Analysis By Product (Consumables, Instruments, Services, Software and Other Products), Technology (Cell-based Assays, Lab-on-a-Chip Technology (LOC), Label-free Technology, Ultra High Throughput Screening and Other Technologies), Application (Drug Discovery, Biochemical Screening, Life Sciences Research and Other Applications), End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $25.70 BN |
|
Projected Year Value (2030) |
US $62.75 BN |
|
CAGR (2023 - 2030) |
13.6% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global High Throughput Screening Market is accounted for $25.70 billion in 2023 and is expected to reach $62.75 billion by 2030 growing at a CAGR of 13.6% during the forecast period. A crucial procedure in biotechnology, pharmaceutical, and life sciences research is high-throughput screening, or HTS. In order to determine which chemicals are active or to learn more about how they affect biological systems, a vast number of chemical or biological molecules must be rapidly tested. Furthermore, HTS processes thousands, even millions, of samples in a comparatively short amount of time by utilizing automated and robotic systems. Drug discovery relies heavily on this technology, which aids in the identification of possible drug candidates, the investigation of their interactions with biological targets, and the evaluation of their safety and effectiveness.
According to the data published by the Congressional Budget Office, in 2021, it has been observed that pharmaceutical industries have spent nearly USD 200 billion on research and development in 2020 globally compared to USD 83 million in 2019.
Market Dynamics:
Driver:
Drug development and discovery
Modern drug discovery and development efforts are built on the foundation of HTS. Innovative medications are always being sought after by the pharmaceutical industry to treat a variety of illnesses, from cancer to uncommon genetic conditions. Moreover, thousands of compounds can be quickly screened with HTS to find promising drug candidates, greatly accelerating and cutting costs associated with the drug development process.
Restraint:
Large initial expenses
HTS technologies and systems require large upfront costs. For startups, smaller research organizations, and academic institutions in particular, the cost of advanced assay technologies, robotics, and high-throughput screening equipment can be prohibitive. Additionally, external funding or collaborations are frequently required to cover these upfront costs.
Opportunity:
Integration of AI and machine learning
HTS procedures could undergo a revolution if machine learning and artificial intelligence (AI) are integrated. These technologies can predict the behavior of compounds, analyze large datasets, and enhance screening procedures. Furthermore, the efficiency and financial viability of drug discovery can be greatly increased by using AI-driven algorithms to greatly improve hit identification, lead optimization, and compound prioritization.
Threat:
Lack of economic clarity
The HTS market may be significantly impacted by recessions, downturns in the economy, or shifts in research funding. HTS research and development may slow down as a result of reduced funding from both the pharmaceutical industry and academia, which would limit investment in and innovation from cutting-edge technologies. Moreover, long-term projects can be derailed, and access to necessary resources can be impeded by economic instability.
Covid-19 Impact:
The high-throughput screening (HTS) market was impacted by the COVID-19 pandemic in a number of ways. The need for quick drug discovery and vaccine development greatly accelerated the adoption of HTS technologies to screen and identify possible treatments for the virus, even though supply chain disruptions, laboratory closures, and resource shortages initially slowed down research and development activities. This led to an increase in demand for vaccine development, biological research on the virus, and screening of antiviral compounds in the HTS market. Furthermore, the pandemic highlighted the significance of automated and remote-capable HTS systems, enabling researchers to carry out their work while abiding by safety precautions and social distancing.
The Cell-based Assays segment is expected to be the largest during the forecast period
In the high-throughput screening (HTS) market, cell-based assays hold the largest market share. A vital part of drug discovery and research, cell-based assays use living cells to examine their reactions to different substances. In addition to facilitating the screening of compounds in more biologically relevant contexts, they offer insightful information about the possible toxicity and efficacy of therapeutic candidates. Moreover, cell-based assays are fundamental to the HTS market, accounting for a sizeable portion of the market share, and have a wide range of applications, such as drug screening, toxicity testing, and target identification. They play a special role in figuring out possible treatment candidates and comprehending the intricate mechanisms underlying diseases.
The Drug Discovery segment is expected to have the highest CAGR during the forecast period
In the high-throughput screening (HTS) market, drug discovery is the segment with the highest CAGR. The rising demand for novel medications and treatments across a range of disease states is a major driver of market growth for HTS. Drug discovery, which includes optimizing lead compounds and identifying possible drug candidates, mainly depends on HTS technologies for quick and effective screening. Additionally, the development of new drugs has accelerated due to the streamlining of drug discovery processes brought about by advances in automation, robotics, and data analysis.
Region with largest share:
The high-throughput screening (HTS) market is anticipated to hold the largest share in the North American region. Significant investments in research and development, a well-established pharmaceutical and biotechnology industry, and a strong need for cutting-edge drug discovery and development technologies are all considered contributing factors to this dominance. Further bolstering North America's standing as a major player in the HTS market is the existence of top HTS equipment manufacturers and research facilities, as well as supportive government initiatives and funding. Furthermore, North America leads the world in the use of HTS technologies due to the region's strong healthcare system and emphasis on precision medicine.
Region with highest CAGR:
In the high-throughput screening (HTS) market, the Asia-Pacific region is growing at the highest CAGR. The growing emphasis on precision medicine in nations like China and India, as well as increased investments in biotechnology and pharmaceutical research, are driving this rapid growth. Clinical trials and drug discovery initiatives find the region appealing due to its large and diverse patient population and cost-effective research and development capabilities. Moreover, a rise in life sciences research endeavors and government backing also play a significant role in the impressive expansion of the Asia-Pacific HTS market, securing the region's standing as a major engine of global HTS market growth.
Key players in the market
Some of the key players in High Throughput Screening market include GE Healthcare, Danaher Corporation, Agilent Technologies Inc, Tecan Group Ltd., Corning Incorporated, Sigma-Aldrich Corporation, Charles River Laboratories International, Inc, Axxam SpA, Thermo Fisher Scientific, Inc., Hamilton Company, Bio-Rad Laboratories, Inc, Merck KGaA, Promega Corporation, BioTek Instruments, Inc., PerkinElmer Inc., Luminex Corporation , Aurora Biomed Inc, NanoTemper Technologies GmbH, Beckman Coulter Inc. and DIANA Biotechnologies, s.r.o.
Key Developments:
In October 2023, GE HealthCare announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based Company, to develop, manufacture and commercialize SOFIE’s Gallium-68 and Fluorine-18 labelled diagnostics targeting fibroblast activation protein (FAP). Financial terms were not disclosed.
In August 2023, Danaher will acquire all outstanding Abcam shares for $24 per share in cash, with a total enterprise value of approximately $5.7 billion, including Abcam’s assumed debts and net of acquired cash. Danaher plans to fund the acquisition using cash on hand and proceeds from the issuance of commercial paper.
In March 2023, Agilent Technologies Inc announced a multi-year distribution agreement with Proscia® – a leader in digital pathology – to offer a comprehensive digital diagnostic pathology system. Combining Agilent's trusted pathology staining solutions with Proscia’s Concentriq® Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality to improve patient health outcomes.
Products Covered:
• Consumables
• Instruments
• Services
• Software
• Other Products
Technologies Covered:
• Cell-based Assays
• Lab-on-a-Chip Technology (LOC)
• Label-free Technology
• Ultra High Throughput Screening
• Other Technologies
Applications Covered:
• Drug Discovery
• Biochemical Screening
• Life Sciences Research
• Other Applications
End Users Covered:
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global High Throughput Screening Market, By Product
5.1 Introduction
5.2 Consumables
5.2.1 Reagents & Assay Kits
5.2.2 Laboratory Equipment
5.3 Instruments
5.3.1 Liquid Handling Systems
5.3.2 Detection Systems
5.3.3 Other Instruments
5.4 Services
5.5 Software
5.6 Other Products
6 Global High Throughput Screening Market, By Technology
6.1 Introduction
6.2 Cell-based Assays
6.2.1 2D Cell Culture
6.2.2 3D Cell Culture
6.2.2.1 Scaffold-based Technology
6.2.2.2 Hydrogels
6.2.2.3 Animal-derived Hydrogels
6.2.2.4 Matrigel
6.2.2.5 Collagen
6.2.2.6 Synthetic Hydrogels
6.2.2.7 Alginate/Agarose
6.2.2.8 Inert Matrix/Solid Scaffolds
6.2.2.9 Micropatterned Surfaces
6.2.2.10 Scaffold-free Technology
6.2.2.11 Ultra-low Binding Plates
6.2.2.12 Hanging-drop Plates
6.2.2.13 Other Scaffold-free Technologies
6.2.3 Reporter-based Assays
6.2.4 Perfusion Cell Culture
6.3 Lab-on-a-Chip Technology (LOC)
6.4 Label-free Technology
6.5 Ultra High Throughput Screening
6.6 Other Technologies
7 Global High Throughput Screening Market, By Application
7.1 Introduction
7.2 Drug Discovery
7.3 Biochemical Screening
7.4 Life Sciences Research
7.5 Other Applications
8 Global High Throughput Screening Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.3 Academic & Research Institutes
8.4 Contract Research Organizations (CROs)
8.5 Other End Users
9 Global High Throughput Screening Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 GE Healthcare
11.2 Danaher Corporation
11.3 Agilent Technologies Inc
11.4 Tecan Group Ltd.
11.5 Corning Incorporated
11.6 Sigma-Aldrich Corporation
11.7 Charles River Laboratories International, Inc
11.8 Axxam SpA
11.9 Thermo Fisher Scientific, Inc.
11.10 Hamilton Company
11.11 Bio-Rad Laboratories, Inc
11.12 Merck KGaA
11.13 Promega Corporation
11.14 BioTek Instruments, Inc.
11.15 PerkinElmer Inc.
11.16 Luminex Corporation
11.17 Aurora Biomed Inc
11.18 NanoTemper Technologies GmbH
11.19 Beckman Coulter Inc.
11.20 DIANA Biotechnologies, s.r.o.
List of Tables
1 Global High Throughput Screening Market Outlook, By Region (2021-2030) ($MN)
2 Global High Throughput Screening Market Outlook, By Product (2021-2030) ($MN)
3 Global High Throughput Screening Market Outlook, By Consumables (2021-2030) ($MN)
4 Global High Throughput Screening Market Outlook, By Reagents & Assay Kits (2021-2030) ($MN)
5 Global High Throughput Screening Market Outlook, By Laboratory Equipment (2021-2030) ($MN)
6 Global High Throughput Screening Market Outlook, By Instruments (2021-2030) ($MN)
7 Global High Throughput Screening Market Outlook, By Liquid Handling Systems (2021-2030) ($MN)
8 Global High Throughput Screening Market Outlook, By Detection Systems (2021-2030) ($MN)
9 Global High Throughput Screening Market Outlook, By Other Instruments (2021-2030) ($MN)
10 Global High Throughput Screening Market Outlook, By Services (2021-2030) ($MN)
11 Global High Throughput Screening Market Outlook, By Software (2021-2030) ($MN)
12 Global High Throughput Screening Market Outlook, By Other Products (2021-2030) ($MN)
13 Global High Throughput Screening Market Outlook, By Technology (2021-2030) ($MN)
14 Global High Throughput Screening Market Outlook, By Cell-based Assays (2021-2030) ($MN)
15 Global High Throughput Screening Market Outlook, By 2D Cell Culture (2021-2030) ($MN)
16 Global High Throughput Screening Market Outlook, By 3D Cell Culture (2021-2030) ($MN)
17 Global High Throughput Screening Market Outlook, By Reporter-based Assays (2021-2030) ($MN)
18 Global High Throughput Screening Market Outlook, By Perfusion Cell Culture (2021-2030) ($MN)
19 Global High Throughput Screening Market Outlook, By Lab-on-a-Chip Technology (LOC) (2021-2030) ($MN)
20 Global High Throughput Screening Market Outlook, By Label-free Technology (2021-2030) ($MN)
21 Global High Throughput Screening Market Outlook, By Ultra High Throughput Screening (2021-2030) ($MN)
22 Global High Throughput Screening Market Outlook, By Other Technologies (2021-2030) ($MN)
23 Global High Throughput Screening Market Outlook, By Application (2021-2030) ($MN)
24 Global High Throughput Screening Market Outlook, By Drug Discovery (2021-2030) ($MN)
25 Global High Throughput Screening Market Outlook, By Biochemical Screening (2021-2030) ($MN)
26 Global High Throughput Screening Market Outlook, By Life Sciences Research (2021-2030) ($MN)
27 Global High Throughput Screening Market Outlook, By Other Applications (2021-2030) ($MN)
28 Global High Throughput Screening Market Outlook, By End User (2021-2030) ($MN)
29 Global High Throughput Screening Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
30 Global High Throughput Screening Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
31 Global High Throughput Screening Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
32 Global High Throughput Screening Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
